Skip to content

Clinical trials

Recruiting Macular Degeneration trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Status: Recruiting Country / region: United States Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20111
20121
20131
20141
20161
20181
20191
20213
20225
20232
20246
202516
202616

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting56

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of California, San Francisco3
4D Molecular Therapeutics2
Astellas Institute for Regenerative Medicine2
EyeBiotech Ltd.2
National Eye Institute (NEI)2
Regeneron Pharmaceuticals2
AI-Spectral1
AbbVie1
Adverum Biotechnologies, Inc.1
Aptabio Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration56
Geographic Atrophy19
Retinal Diseases6
Retinitis Pigmentosa6
Stargardt Disease6
Diabetic Retinopathy5
Eye Diseases5
Wet Macular Degeneration5
Glaucoma4
Retinal Degeneration4

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.